EAM
Exane Asset Management Portfolio holdings
AUM
$256M
This Quarter Return
-6.27%
1 Year Return
+8.08%
3 Year Return
+70.48%
5 Year Return
+81.39%
10 Year Return
–
AUM
$170M
AUM Growth
+$170M
(-47%)
Cap. Flow
-$123M
Cap. Flow
% of AUM
-72.33%
Top 10 Holdings %
Top 10 Hldgs %
68.38%
Holding
199
New
70
Increased
19
Reduced
16
Closed
92
Top Buys
| 1 |
Takeda Pharmaceutical
TAK
|
$15.7M |
| 2 |
T-Mobile US
TMUS
|
$11.4M |
| 3 |
AT&T
T
|
$11.1M |
| 4 |
Sherwin-Williams
SHW
|
$7.05M |
| 5 |
RHT
Red Hat Inc
RHT
|
$5.27M |
Top Sells
| 1 |
Qiagen
QGEN
|
$19.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
$13.9M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12M |
| 4 |
UBS Group
UBS
|
$11M |
| 5 |
Gilead Sciences
GILD
|
$10.2M |
Sector Composition
| 1 | Materials | 31.17% |
| 2 | Communication Services | 24.88% |
| 3 | Healthcare | 19.33% |
| 4 | Utilities | 7.37% |
| 5 | Technology | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Air Products & Chemicals
APD
$65.5B
| $16.9M | 9.93% | 105,714 +2,426 | +2% | +$388K |
|
|
2
T-Mobile US
TMUS
$284B
| $16.3M | 9.58% | 256,769 +179,607 | +233% | +$11.4M |
|
|
3
Takeda Pharmaceutical
TAK
$47.3B
| $15.7M | 9.21% | +933,466 | New | +$15.7M |
|
|
4
Sherwin-Williams
SHW
$91.2B
| $15.1M | 8.85% | 38,312 +17,923 | +88% | +$7.05M |
|
|
5
AT&T
T
$209B
| $11.1M | 6.5% | +388,308 | New | +$11.1M |
|
6
Ashland
ASH
$2.57B
| $10.6M | 6.22% | 149,345 -64,553 | -30% | -$4.58M |
|
7
PPG Industries
PPG
$25.1B
| $9.21M | 5.41% | 90,108 +9,059 | +11% | +$926K |
|
|
TFCFA
8
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $8.27M | 4.85% | 171,879 -57,779 | -25% | -$2.78M |
|
|
VVC
9
DELISTED
Vectren Corporation
VVC
| $6.74M | 3.95% | 93,587 +57,524 | +160% | +$4.14M |
|
|
SHPG
10
DELISTED
Shire pic
SHPG
| $6.62M | 3.88% | 38,012 -25,388 | -40% | -$4.42M |
|
|
RHT
11
DELISTED
Red Hat Inc
RHT
| $5.27M | 3.09% | +30,000 | New | +$5.27M |
|
|
DNB
12
DELISTED
Dun & Bradstreet
DNB
| $4.28M | 2.51% | 30,000 | – | – |
|
|
13
Bristol-Myers Squibb
BMY
$96B
| $3.04M | 1.78% | 58,393 -266,748 | -82% | -$13.9M |
|
|
IMPV
14
DELISTED
Imperva, Inc.
IMPV
| $2.33M | 1.37% | +41,864 | New | +$2.33M |
|
|
BEL
15
DELISTED
Belmond Ltd.
BEL
| $2.2M | 1.29% | +88,035 | New | +$2.2M |
|
16
Upbound Group
UPBD
$1.47B
| $2.03M | 1.19% | 125,622 -52,167 | -29% | -$845K |
|
17
NXP Semiconductors
NXPI
$59.2B
| $1.86M | 1.09% | 25,412 -7,000 | -22% | -$513K |
|
18
FirstEnergy
FE
$25.2B
| $1.84M | 1.08% | 49,075 +18,148 | +59% | +$681K |
|
|
APTI
19
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $1.77M | 1.04% | +46,728 | New | +$1.77M |
|
20
Dominion Energy
D
$51.1B
| $1.76M | 1.03% | 24,644 +8,449 | +52% | +$604K |
|
21
ON Semiconductor
ON
$20.3B
| $1.61M | 0.94% | 97,237 -4,536 | -4% | -$74.9K |
|
22
Resideo Technologies
REZI
$5.07B
| $1.44M | 0.84% | +70,000 | New | +$1.44M |
|
|
ALXN
23
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.44M | 0.84% | 14,758 -123,162 | -89% | -$12M |
|
|
24
Gilead Sciences
GILD
$140B
| $1.37M | 0.8% | 21,831 -162,624 | -88% | -$10.2M |
|
25
Logitech
LOGI
$15.3B
| $1.35M | 0.79% | 42,755 +39,559 | +1,238% | +$1.24M |
|